on FERMENTALG (EPA:FALG)
Fermentalg Completes €11 Million Capital Increase for Growth
Fermentalg, a prominent developer of sustainable biosolutions, has successfully raised nearly €11 million through a capital increase. This move aims to bolster its commercial development. CEO Pierre Josselin expressed gratitude to investors, notably Vatel Capital and Huvepharma Group, for their continued trust and commitment. The raised funds will support the expansion of Fermentalg's biosolutions range.
The transaction, totaling €10,913,953.10, was executed via the issuance of 23,725,985 new shares. The share price was set at €0.46, a 20% discount on the recent average trading price. The new shares are set to be traded on Euronext Growth Paris from May 15, 2026.
Post-transaction, Fermentalg's share capital will consist of 119,939,198 shares. While intended to strengthen development, existing shareholders may experience a decrease in their percentage holdings. Additional financial communications are scheduled for July 16, 2026.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all FERMENTALG news